Anavex Life Sciences Corporation (AVXL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVXL? Forum Prognose Aktiensplit

Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.01% 1.079	0.999	1.075	1.21	1.394
Operating Expenses	37.46% 6.782	10.84	14.46	12.51	13.59
Benefits Costs and Expenses	100.00% -	51.05	-	-	-
Costs And Expenses	15.40% 7.861	6.812	15.53	13.72	14.99
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	37.46% -6.782	-10.84	-14.46	-12.51	-13.59
Net Interest Income/Expense	8.01% 1.079	0.999	1.075	1.21	1.394
Nonoperating Income/Loss	10.03% 1.119	1.017	1.216	1.317	1.481
Income/Loss From Continuing Operations Before Tax	102.16% 1.079	-50.06	1.075	1.21	1.394
Income/Loss From Continuing Operations After Tax	42.19% -5.681	-9.827	-13.24	-11.20	-12.11
Net Income/Loss	42.19% -5.681	-9.827	-13.24	-11.20	-12.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	43,616% 89.03	0.2037	85.38	85.07	84.81
Diluted Average Shares	43,616% 89.03	0.2037	85.38	85.07	84.81
Basic Earnings Per Share	45.45% -0.06	-0.11	-0.16	-0.13	-0.14
Diluted Earnings Per Share	45.45% -0.06	-0.11	-0.16	-0.13	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%